Medical research caught in cross-fire of R&D tax overhaul


9 April 2018 - Industry commercialising medical research caught in cross-fire of R&D tax overhaul.

AusBiotech, Australia’s life sciences industry organisation says the sector will be damaged in the cross-fire, if the Treasury pushes ahead with plans to cap the Research and Development Tax Incentive (RDTI).

Treasurer Scott Morrison has flagged an overhaul of the RDTI in the coming May Budget, which will seek to restore the “integrity of the program” after accusations of “mining of tax incentives” and “arbitrary use”.

Read AusBiotech press release

Michael Wonder

Posted by:

Michael Wonder